Skip to main content
FATE logo

FATE · Fate Therapeutics Inc

Track FATE — free
$2.57 +0.05 (+1.98%) At close · Aug 14
Market Cap
$307.94M
Shares
119.82M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended Cash Spent
2011-12-31 $7,000
Key facts CIK 1434316 CUSIP 31189P102 13F (30d) 145 filings 144 filers Visit website Investor relations